NIH begins clinical trial of hydroxychloroquine and azithromycin to treat coronavirus patients
NIH doses first coronavirus patient in trial of hydroxychloroquine and antibiotic combo touted by Trump in hopes the controversial drug will cut risks of hospitalization and death The NIH has begun a clinical trial testing anti-malaria drug hydroxychloroquine and antibiotic azithromycin in coronavirus patients Patients will either be assigned the experimental treatment or a pair … Read more